🧬

Biyoteknoloji Sektörü Hisseleri

Biyoteknoloji Sektörü altında 614 Hisse Senedi

Biyoteknoloji sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.

Biyoteknoloji Sektörü Hakkında

Biyoteknoloji sektörü, genetik mühendisliği, ilaç geliştirme ve tıbbi araştırma alanında faaliyet gösteren şirketleri kapsar. Yüksek AR-GE yatırımları ve uzun geliştirme süreçleri ile karakterize edilir.

Temel Özellikler

  • Yüksek AR-GE yatırımları
  • Uzun geliştirme süreçleri
  • Düzenleyici onay riskleri
  • Yüksek büyüme potansiyeli

Önemli Şirketler

ModernaGilead SciencesBiogenRegeneron
100
Toplam Hisse
$47.7B
Toplam Piyasa Değeri

Biyoteknoloji Sektörü Hisseleri

Sayfa 3/7 (Toplam: 614)
SEMBOLŞİRKETPİYASA DEĞERİFİYATDEĞİŞİM
STOKStoke Therapeutics, Inc.$740.88M$13.5710.24%
XRXXerox Holdings Corporation$733.36M$5.8312.12%
MNMDMind Medicine (MindMed) Inc.$728.33M$9.643.12%
CDNACareDx, Inc$724.96M$13.022.12%
TNGXTango Therapeutics, Inc.$724.07M$6.681.33%
EYPTEyePoint Pharmaceuticals, Inc.$719.08M$10.450.85%
AMLXAmylyx Pharmaceuticals, Inc.$701.54M$7.874.14%
VMEOVimeo, Inc.$696.87M$4.234.96%
MGTXMeiraGTx Holdings plc$690.34M$8.591.15%
TSHATaysha Gene Therapies, Inc.$687.82M$2.634.16%
MRVIMaravai LifeSciences Holdings, Inc.$677.65M$2.536.30%
DAWNDay One Biopharmaceuticals, Inc.$665.95M$6.572.66%
XNCRXencor, Inc.$654.77M$9.201.10%
GYREGyre Therapeutics, Inc.$653.04M$7.231.83%
BBNXBeta Bionics, Inc.$648.61M$14.964.62%
RLAYRelay Therapeutics, Inc.$636.06M$3.712.20%
ZVRAZevra Therapeutics, Inc.$633.19M$11.581.28%
BCAXBicara Therapeutics Inc. Common Stock$624.44M$11.451.87%
EOLSEvolus, Inc.$617.03M$9.573.80%
ORGOOrganogenesis Holdings Inc.$611.44M$4.825.70%
WEAVWeave Communications, Inc.$609.72M$8.113.71%
PRMEPrime Medicine, Inc.$609.27M$4.530.88%
ABUSArbutus Biopharma Corporation$603.31M$3.150.32%
ZBIOZenas BioPharma, Inc.$598.65M$14.310.14%
UPBUpstream Bio, Inc.$578.28M$10.751.03%
KURAKura Oncology, Inc.$577.45M$6.673.09%
AXGNAxoGen, Inc.$571.12M$12.548.01%
PSNLPersonalis, Inc.$567.93M$6.433.71%
FLGTFulgent Genetics, Inc.$567.16M$18.634.96%
RGLSRegulus Therapeutics Inc.$564.95M$8.160.00%
KROSKeros Therapeutics, Inc.$557.65M$13.730.44%
SEPNSepterna, Inc.$555.64M$12.471.30%
ARVNArvinas, Inc.$553.27M$7.580.80%
PHATPhathom Pharmaceuticals, Inc.$551.53M$7.900.89%
SAGESage Therapeutics, Inc.$547.95M$8.752.45%
TYRATyra Biosciences, Inc.$547.20M$10.293.02%
TERNTerns Pharmaceuticals, Inc.$524.03M$6.006.38%
ZIMVZimVie Inc.$522.97M$18.730.16%
LABStandard BioTools Inc.$516.56M$1.367.94%
SIGASIGA Technologies, Inc.$489.37M$6.850.00%
PACBPacific Biosciences of California, Inc.$486.14M$1.6212.11%
TRMLTourmaline Bio, Inc.$484.49M$18.863.46%
SLDBSolid Biosciences Inc.$482.92M$6.232.20%
CGEMCullinan Oncology, Inc.$478.61M$8.117.85%
ERASErasca, Inc.$475.92M$1.6812.00%
RZLTRezolute, Inc.$467.17M$5.370.19%
ATYRaTyr Pharma, Inc.$466.38M$5.248.23%
ABSIAbsci Corporation$463.04M$3.633.42%
SRDXSurmodics, Inc.$456.22M$31.912.36%
PGENPrecigen, Inc.$448.67M$1.5216.94%
PRTCPureTech Health plc$445.67M$18.555.68%
SENSSenseonics Holdings, Inc.$437.49M$0.580.38%
LXRXLexicon Pharmaceuticals, Inc.$435.81M$1.202.44%
RGNXREGENXBIO Inc.$431.83M$8.570.94%
CMPXCompass Therapeutics, Inc.$424.53M$3.070.00%
NKTRNektar Therapeutics$423.53M$24.481.25%
MYGNMyriad Genetics, Inc.$423.09M$4.593.15%
AURAAura Biosciences, Inc.$419.77M$6.770.00%
SVRASavara Inc.$416.54M$2.415.24%
TECXTectonic Therapeutic, Inc.$414.90M$22.221.37%
CTKBCytek Biosciences, Inc.$411.64M$3.254.84%
AQSTAquestive Therapeutics, Inc.$394.33M$3.976.15%
ARCTArcturus Therapeutics Holdings Inc.$394.06M$14.535.37%
MBXMBX Biosciences, Inc. Common Stock$391.07M$11.704.02%
GOSSGossamer Bio, Inc.$390.96M$1.721.71%
EBSEmergent BioSolutions Inc.$388.63M$7.163.17%
ITOSiTeos Therapeutics, Inc.$387.33M$10.120.10%
VIGLVigil Neuroscience, Inc.$384.35M$8.060.25%
FULCFulcrum Therapeutics, Inc.$380.55M$7.050.70%
CTMXCytomX Therapeutics, Inc.$376.53M$2.390.42%
CYRXCryoport, Inc.$372.52M$7.4310.73%
ANGOAngioDynamics, Inc.$370.74M$9.131.56%
TMCITreace Medical Concepts, Inc.$370.51M$5.892.97%
VPGVishay Precision Group, Inc.$369.61M$27.880.18%
RCKTRocket Pharmaceuticals, Inc.$363.08M$3.377.67%
QSIQuantum-Si incorporated$363.06M$1.804.65%
RIGLRigel Pharmaceuticals, Inc.$358.52M$20.062.40%
HUMAHumacyte, Inc.$356.77M$2.300.00%
FHTXFoghorn Therapeutics Inc.$353.40M$6.343.93%
XPERXperi Inc.$348.59M$7.630.26%
GLUEMonte Rosa Therapeutics, Inc.$348.15M$5.662.92%
ALMSAlumis Inc. Common Stock$341.56M$3.310.30%
ALTAltimmune, Inc.$340.65M$4.203.70%
CRVSCorvus Pharmaceuticals, Inc.$333.91M$4.332.70%
ABEOAbeona Therapeutics Inc.$333.54M$6.523.41%
INBXInhibrx Biosciences, Inc.$330.92M$22.863.35%
TNXPTonix Pharmaceuticals Holding Corp.$329.23M$44.750.78%
ALDXAldeyra Therapeutics, Inc.$321.04M$5.360.56%
CATXPerspective Therapeutics, Inc.$319.18M$4.300.23%
RNACCartesian Therapeutics, Inc.$316.12M$12.181.08%
VREXVarex Imaging Corporation$314.57M$7.582.36%
NGNENeurogene Inc.$312.91M$21.941.29%
OLMAOlema Pharmaceuticals, Inc.$310.63M$4.541.09%
ALLOAllogene Therapeutics, Inc.$310.60M$1.427.58%
UISUnisys Corporation$309.85M$4.363.07%
NPCENeuroPace, Inc.$306.67M$9.350.11%
NMRANeumora Therapeutics, Inc. Common Stock$305.70M$1.893.57%
XOMAXOMA Corporation$304.56M$25.450.12%
OCGNOcugen, Inc.$300.79M$1.031.98%
CAPRCapricor Therapeutics, Inc.$298.01M$6.523.99%
ÖncekiSayfa 3 / 7Sonraki